British Journal of Haematology

SJR Rank #2,561H-index: 220SJR: 1.455Best quartile: Q1APC: US$5,190
Journal website: aims, scope and author guidelines
Publisher

John Wiley and Sons Inc

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • HematologyQ1

Areas: Medicine

Most published research topics

Acute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentPlatelet Disorders and TreatmentsHemoglobinopathies and Related DisordersChronic Lymphocytic Leukemia ResearchBlood groups and transfusionAcute Lymphoblastic Leukemia researchHematopoietic Stem Cell TransplantationMyeloproliferative Neoplasms: Diagnosis and TreatmentErythrocyte Function and Pathophysiology

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0500100015002000

Documents per Year

202220250200400600800

Detailed Information

ISSN

1365-2141, 0007-1048

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

2.64

References per Document

28.79

Coverage

1955-2026

Scope

The mission of the British Journal of Haematology (BJHaem) is to inform and educate its readership in all aspects of the clinical and laboratory practice of haematology, extending from its scientific basis, through translational research, to clinical trials and daily practice. The journal welcomes manuscripts in cutting edge science and new treatments including targeted therapy, molecular and gene therapy and immunotherapy. The journal also focuses on evidence-based medicine by publishing peer-reviewed Guidelines on various basic and clinical subjects resulting from committees formed by the British Society for Haematology.

Metrics from SCImago Journal Rank 2025. View on SCImago